PRINCETON, NJ--(Marketwire - December 20, 2007) - Agile Therapeutics, Inc., a specialty pharmaceutical company focused on the development of innovative women's healthcare products, today announced that it has raised USD $5.6 million in an extension of its Series E financing round, bringing the total of the round to USD $17.6 million. Current investors participated in the round including, The Hillman Company, ProQuest Investments, TL Ventures and Novitas Capital (formerly PA Early Stage Partners).
